Reduced cerebral blood flow in an α -synuclein transgenic mouse model of Parkinson’s disease

Abstract excerpt

There is increasing evidence that widespread cortical cerebral blood flow deficits occur early in the course of Parkinson's disease. Although cerebral blood flow measurement has been suggested as a potential biomarker for early diagnosis of Parkinson's disease, as well as a means for tracking response to treatment, the relationship of cerebral blood flow to α-synucleinopathy, a major pathological hallmark of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Nerve injury and regeneration
• Share to Nuclear Receptors and Signaling
• Share to Parkinson's Disease Mechanisms and Treatments